^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
Oncuria™

Type:
CE Marked

Details

Evidence
Oncuria™ is designed to detect 10 proteins by ELISA in urine specimens from persons with hematuria suspected of having bladder cancer or urine specimens from persons with a history of bladder cancer on tumor surveillance. Results from Oncuria™ are intended for use, in conjunction with, and not in lieu of, current standard diagnostic procedures as an aid for initial diagnosis of bladder cancer in patients with hematuria, and for subsequent monitoring of tumor recurrence in patients previously diagnosed with bladder cancer.
Cancer:
Bladder Cancer
Method:
ELISA
Approvals
Date
Cancer
Gene
Drug
By
06/16/22
CE